Myocardial ischemia is a medical ailment characterized by a diminished supply of blood to the heart muscle, typically arising from the constriction or blockage of coronary arteries. This reduction in blood flow causes the heart muscle to be deprived of oxygen and essential nutrients, potentially resulting in damage or cell death. A primary contributor to myocardial ischemia is atherosclerosis, a condition where the coronary arteries narrow due to the accumulation of fatty deposits, cholesterol, and other substances. The symptoms of myocardial ischemia often manifest as angina, which is characterized by chest pain or discomfort. In severe instances, myocardial ischemia can progress to a heart attack. Prompt diagnosis and intervention play a pivotal role in managing myocardial ischemia and averting further complications. The emphasis lies on a multifaceted approach encompassing lifestyle modifications, medication, and, in certain cases, surgical interventions aimed at restoring blood flow and preserving optimal heart function. Timely and appropriate medical attention is imperative in addressing myocardial ischemia and preventing its progression to more severe cardiac events.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt